Trial intelligence / Profile preview

Oxycodone ED90 Dose for Perioperative Multimodal Analgesia in Elderly Thoracoscopic Lobectomy

ChiCTR2300071956Phase 4Recruiting

Sponsor
Shengjing Hospital of China Medical University
Start
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of oxycodone in bronchial carcinoma, sponsored by Shengjing Hospital of China Medical University. Primary endpoint: Numeric Rating Scale (NRS) score at cough 2 hours after surgery. Started Apr 2023; status: recruiting.

02

Drugs

oxycodone
03

Conditions

bronchial carcinoma

Beyond the preview

Go deeper on ChiCTR2300071956.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300071956.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call